Systems approach to tuberculosis vaccine development (Q38075096)

28 August 2017

Systems approach to tuberculosis vaccine development (English)

1 reference

28 August 2017

0 references

4

Brigitte Gicquel

0 references

Xionglin Fan

object named as

Xionglin Fan

3

0 references

author name string

Charles C Wang

1

1 reference

PubMed ID

23331331

28 August 2017

Bingdong Zhu

2

1 reference

PubMed ID

23331331

28 August 2017

Ying Zhang

5

1 reference

28 August 2017

1 April 2013

1 reference

28 August 2017

1 reference

28 August 2017

18

1 reference

28 August 2017

3

1 reference

28 August 2017

412-420

1 reference

Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics

28 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Future Vaccination Strategies against Tuberculosis: Thinking outside the Box

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Vaccines: correlates of vaccine-induced immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Immunology of tuberculosis and implications in vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

The immunology of tuberculosis: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Secondary lymphoid organs are dispensable for the development of T-cell-mediated immunity during tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Floating between the poles of pathology and protection: can we pin down the granuloma in tuberculosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Vaccines against tuberculosis: where are we and where do we need to go?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Beyond empiricism: informing vaccine development through innate immunity research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Intravital imaging reveals limited antigen presentation and T cell effector function in mycobacterial granulomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Cell-mediated immune responses in tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Human CD4 and CD8 regulatory T cells in infectious diseases and vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Neutrophil-mediated innate immune resistance to mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Neutrophils in tuberculosis: friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Mycobacterium tuberculosis: success through dormancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Targeting persisters for tuberculosis control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

New vaccines for tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

A multistage tuberculosis vaccine that confers efficient protection before and after exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Prospects for a new, safer and more effective TB vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Novel tuberculosis vaccines on the horizon

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Immunogenicity and protective efficacy of a novel recombinant BCG strain overexpressing antigens Ag85A and Ag85B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Tuberculosis vaccine development: strength lies in tenacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

A booster vaccine expressing a latency-associated antigen augments BCG induced immunity and confers enhanced protection against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Preclinical evidence for implementing a prime-boost vaccine strategy for tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Boosting with mycobacterial heparin-binding haemagglutinin enhances protection of Mycobacterium bovis BCG-vaccinated newborn mice against M. tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Immunogenicity and protective efficacy against murine tuberculosis of a prime-boost regimen with BCG and a DNA vaccine expressing ESAT-6 and Ag85A fusion protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

A DNA vaccine expressing CFP21 and MPT64 fusion protein enhances BCG-induced protective immunity against Mycobacterium tuberculosis infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

How B cells shape the immune response against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Human gene expression profiles of susceptibility and resistance in tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Deciphering the genetic architecture of variation in the immune response to Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Adjuvants in tuberculosis vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Systems biology of persistent infection: tuberculosis as a case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Kinetic modeling of tricarboxylic acid cycle and glyoxylate bypass in Mycobacterium tuberculosis, and its application to assessment of drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Systems biology approaches to understanding mycobacterial survival mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

GSMN-TB: a web-based genome-scale network model of Mycobacterium tuberculosis metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Investigating the metabolic capabilities of Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and proposing alternative drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Interpreting expression data with metabolic flux models: predicting Mycobacterium tuberculosis mycolic acid production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Modeling the immune rheostat of macrophages in the lung in response to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Mathematical modeling of tuberculosis bacillary counts and cellular populations in the organs of infected mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Properties and protective value of the secondary versus primary T helper type 1 response to airborne Mycobacterium tuberculosis infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Identification of key processes that control tumor necrosis factor availability in a tuberculosis granuloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

A multifaceted approach to modeling the immune response in tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Systems biology approaches to new vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Tuberculosis research: going forward with a powerful "translational systems biology" approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

The top five "game changers" in vaccinology: toward rational and directed vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Vaccinomics: current findings, challenges and novel approaches for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Mycobacterium bovis-BCG vaccination induces specific pulmonary transcriptome biosignatures in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Comprehensive gene expression profiling in lungs of mice infected with Mycobacterium tuberculosis following DNAhsp65 immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

Creativity in tuberculosis research and discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

A systems perspective of host–pathogen interactions: predicting disease outcome in tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

BCG vaccination: 90 years on and still so much to learn ..

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FRESP.12052

21 January 2018

Identifiers

DOI

10.1111/RESP.12052

1 reference

28 August 2017

1 reference

PubMed ID

23331331